Vera Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Vera Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2021 to Q2 2024.
  • Vera Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $359M, a 144% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $359M +$212M +144% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $335M +$275M +460% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $115M +$43.8M +61.6% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $132M +$48.6M +57.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $147M +$65.6M +80.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $59.8M +$20.3M +51.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $71.2M +$71.2M Dec 31, 2022 10-K 2024-03-27
Q3 2022 $83.9M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $81.5M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $39.4M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.